vs
Privia Health Group, Inc.（PRVA）与越洋钻探（RIG）财务数据对比。点击上方公司名可切换其他公司
越洋钻探的季度营收约是Privia Health Group, Inc.的1.9倍（$1.0B vs $541.2M），越洋钻探净利率更高（2.4% vs 1.7%，领先0.7%），Privia Health Group, Inc.同比增速更快（17.4% vs 9.6%），过去两年越洋钻探的营收复合增速更高（16.9% vs 14.2%）
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
越洋钻探（Transocean Ltd.）是按营收计全球规模最大的海上钻探承包商，总部位于瑞士施泰因豪森，起源于美国，目前在加拿大、美国、挪威、英国、印度、巴西、新加坡等20个国家设有办事机构，业务覆盖全球主要海上油气开采区域。
PRVA vs RIG — 直观对比
营收规模更大
RIG
是对方的1.9倍
$541.2M
营收增速更快
PRVA
高出7.9%
9.6%
净利率更高
RIG
高出0.7%
1.7%
两年增速更快
RIG
近两年复合增速
14.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $541.2M | $1.0B |
| 净利润 | $9.2M | $25.0M |
| 毛利率 | — | 42.0% |
| 营业利润率 | 2.1% | 23.0% |
| 净利率 | 1.7% | 2.4% |
| 营收同比 | 17.4% | 9.6% |
| 净利润同比 | 108.0% | 257.1% |
| 每股收益（稀释后） | $0.08 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRVARIG
| Q4 25 | $541.2M | $1.0B | ||
| Q3 25 | $580.4M | $1.0B | ||
| Q2 25 | $521.2M | $988.0M | ||
| Q1 25 | $480.1M | $906.0M | ||
| Q4 24 | $460.9M | $952.0M | ||
| Q3 24 | $437.9M | $948.0M | ||
| Q2 24 | $422.3M | $861.0M | ||
| Q1 24 | $415.2M | $763.0M |
净利润PRVARIG
| Q4 25 | $9.2M | $25.0M | ||
| Q3 25 | $6.9M | $-1.9B | ||
| Q2 25 | $2.7M | $-938.0M | ||
| Q1 25 | $4.2M | $-79.0M | ||
| Q4 24 | $4.4M | $7.0M | ||
| Q3 24 | $3.5M | $-494.0M | ||
| Q2 24 | $3.5M | $-123.0M | ||
| Q1 24 | $3.0M | $98.0M |
毛利率PRVARIG
| Q4 25 | — | 42.0% | ||
| Q3 25 | — | 43.2% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 31.8% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 40.6% | ||
| Q2 24 | — | 38.0% | ||
| Q1 24 | — | 31.5% |
营业利润率PRVARIG
| Q4 25 | 2.1% | 23.0% | ||
| Q3 25 | 2.5% | -163.1% | ||
| Q2 25 | 0.6% | -97.6% | ||
| Q1 25 | 1.1% | 7.1% | ||
| Q4 24 | 1.1% | 13.7% | ||
| Q3 24 | 1.3% | -51.2% | ||
| Q2 24 | 1.2% | -6.9% | ||
| Q1 24 | 0.2% | -0.4% |
净利率PRVARIG
| Q4 25 | 1.7% | 2.4% | ||
| Q3 25 | 1.2% | -187.1% | ||
| Q2 25 | 0.5% | -94.9% | ||
| Q1 25 | 0.9% | -8.7% | ||
| Q4 24 | 1.0% | 0.7% | ||
| Q3 24 | 0.8% | -52.1% | ||
| Q2 24 | 0.8% | -14.3% | ||
| Q1 24 | 0.7% | 12.8% |
每股收益（稀释后）PRVARIG
| Q4 25 | $0.08 | $0.13 | ||
| Q3 25 | $0.05 | $-2.00 | ||
| Q2 25 | $0.02 | $-1.06 | ||
| Q1 25 | $0.03 | $-0.11 | ||
| Q4 24 | $0.03 | $-0.14 | ||
| Q3 24 | $0.03 | $-0.58 | ||
| Q2 24 | $0.03 | $-0.15 | ||
| Q1 24 | $0.02 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $479.7M | $620.0M |
| 总债务越低越好 | — | $5.2B |
| 股东权益账面价值 | $737.2M | $8.1B |
| 总资产 | $1.4B | $15.6B |
| 负债/权益比越低杠杆越低 | — | 0.64× |
8季度趋势，按日历期对齐
现金及短期投资PRVARIG
| Q4 25 | $479.7M | $620.0M | ||
| Q3 25 | $441.4M | $833.0M | ||
| Q2 25 | $390.1M | $377.0M | ||
| Q1 25 | $469.3M | $263.0M | ||
| Q4 24 | $491.1M | $560.0M | ||
| Q3 24 | $422.0M | $435.0M | ||
| Q2 24 | $387.4M | $475.0M | ||
| Q1 24 | $351.1M | $446.0M |
总债务PRVARIG
| Q4 25 | — | $5.2B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | — | $5.9B | ||
| Q1 25 | — | $5.9B | ||
| Q4 24 | — | $6.2B | ||
| Q3 24 | — | $6.5B | ||
| Q2 24 | — | $6.8B | ||
| Q1 24 | — | $6.8B |
股东权益PRVARIG
| Q4 25 | $737.2M | $8.1B | ||
| Q3 25 | $709.1M | $8.1B | ||
| Q2 25 | $682.9M | $9.4B | ||
| Q1 25 | $659.4M | $10.2B | ||
| Q4 24 | $635.2M | $10.3B | ||
| Q3 24 | $614.9M | $10.2B | ||
| Q2 24 | $595.4M | $10.7B | ||
| Q1 24 | $576.8M | $10.5B |
总资产PRVARIG
| Q4 25 | $1.4B | $15.6B | ||
| Q3 25 | $1.4B | $16.2B | ||
| Q2 25 | $1.3B | $17.8B | ||
| Q1 25 | $1.2B | $19.0B | ||
| Q4 24 | $1.1B | $19.4B | ||
| Q3 24 | $1.1B | $19.5B | ||
| Q2 24 | $1.1B | $20.3B | ||
| Q1 24 | $1.0B | $19.9B |
负债/权益比PRVARIG
| Q4 25 | — | 0.64× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.63× | ||
| Q1 24 | — | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $127.5M | $349.0M |
| 自由现金流经营现金流 - 资本支出 | — | $321.0M |
| 自由现金流率自由现金流/营收 | — | 30.8% |
| 资本支出强度资本支出/营收 | — | 2.7% |
| 现金转化率经营现金流/净利润 | 13.93× | 13.96× |
| 过去12个月自由现金流最近4个季度 | — | $626.0M |
8季度趋势，按日历期对齐
经营现金流PRVARIG
| Q4 25 | $127.5M | $349.0M | ||
| Q3 25 | $52.0M | $246.0M | ||
| Q2 25 | $8.0M | $128.0M | ||
| Q1 25 | $-24.1M | $26.0M | ||
| Q4 24 | $74.8M | $206.0M | ||
| Q3 24 | $33.2M | $194.0M | ||
| Q2 24 | $34.5M | $133.0M | ||
| Q1 24 | $-33.1M | $-86.0M |
自由现金流PRVARIG
| Q4 25 | — | $321.0M | ||
| Q3 25 | — | $235.0M | ||
| Q2 25 | — | $104.0M | ||
| Q1 25 | — | $-34.0M | ||
| Q4 24 | — | $177.0M | ||
| Q3 24 | — | $136.0M | ||
| Q2 24 | — | $49.0M | ||
| Q1 24 | — | $-169.0M |
自由现金流率PRVARIG
| Q4 25 | — | 30.8% | ||
| Q3 25 | — | 22.9% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -3.8% | ||
| Q4 24 | — | 18.6% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | -22.1% |
资本支出强度PRVARIG
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 6.1% | ||
| Q2 24 | — | 9.8% | ||
| Q1 24 | — | 10.9% |
现金转化率PRVARIG
| Q4 25 | 13.93× | 13.96× | ||
| Q3 25 | 7.58× | — | ||
| Q2 25 | 2.97× | — | ||
| Q1 25 | -5.70× | — | ||
| Q4 24 | 17.00× | 29.43× | ||
| Q3 24 | 9.38× | — | ||
| Q2 24 | 9.94× | — | ||
| Q1 24 | -11.10× | -0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
RIG
| Ultra Deepwater Floaters | $433.0M | 42% |
| BR | $236.0M | 23% |
| Other Geographical | $211.0M | 20% |
| Harsh Environment Floaters | $163.0M | 16% |
